CH EPL (R5)
1.0.1 - trial-use Switzerland flag

CH EPL (R5) - Local Development build (v1.0.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

CodeSystem: CH SMC - Authorisation Category

Official URL: http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category Version: 1.0.1
Active as of 2026-04-02 Computable Name: ChSMCAuthorisationCategoryCS

Copyright/Legal: CC0-1.0

CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Authorisation Category)

This Code system is referenced in the content logical definition of the following value sets:

This case-insensitive code system http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category defines the following codes:

CodeDisplayDeutsch (German, de)
756005021001 NA KAS art. 12 para. 5 TPLO NA BWS Art 12. Abs. 5 VAZV
756005021002 NA KAS art. 14 para. 1 abis-quater TPA NA BWS Art. 14 Abs. 1 Bst. a bis-quarter HMG
756005021003 NA KAS with innovation NA BWS mit Innovation
756005021004 KAS CPP BWS KPA
756005021005 NA CP with indication NA KA mit Indikation
756005021006 NA KAS without innovation NA BWS ohne Innovation
756005021007 NA KAS phyto NA BWS Phyto
756005021008 NA Co-Marketing NA Co-Marketing
756005021009 NA CP without indication NA KA ohne Indikation
756005021010 notification procedure teas and pastilles Meldeverfahren Tees und Bonbons
756005021011 NA NAS NA NAS
756005021012 NA NAS art. 14 para. 1 abis-quater TPA NA NAS Art. 14 Abs. 1 Bst. a bis-quarter HMG
756005021013 NA allergen follow-up product NA Allergenanschlusspräparat
756005021014 NA allergen follow-up product NA Allergenpräparat
756005021015 NA phyto traditional NA Phyto traditionell
756005021016 NA phyto well established NA Phyto well established
756005021017 NA parallel import NA Parallelimport
756005021018 NA CP red. Dossier NA KA red. Dossier
756005021019 NA biosimilar NA Biosimilar
756005021020 Notification proceure VP Meldeverfahren TAM
756005021021 Extension for NAS ZE zu NAS
756005021022 Extension for KAS art. 12 para. 5 TPLO ZE zu BWS Art. 12 Abs. 5 VAZV
756005021023 Extension for KAS with innovation ZE zu BWS mit Innovation
756005021024 Extension for biosimilar ZE zu Biosimilar
756005021025 Extension for CP with indication ZE zu KA mit Indikation